Variability of fine particle dose and lung deposition of budesonide delivered through two multidose dry powder inhalers

Author： Munzel U. Marschall K. Fyrnys B. Wedel M.

ISSN： 1473-4877

Source： Current Medical Research and Opinion, Vol.21, Iss.6, 2005-06, pp. : 827-834

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Evaluation of efficacy and safety of budesonide delivered via two dry powder inhalers

By Kerwin Edward M. Pearlman David S. de Guia Teresita Carlsson Lars-Göran Gillen Michael Uryniak Tom Simonson Steven G.

Current Medical Research and Opinion, Vol. 24, Iss. 5, 2008-05 ,pp. : 1497-1510

Informa Healthcare

Access to resources Recommend Favorite

Clinical Equivalence Trial on Budesonide Delivered either by the Novolizer^® Multidose Dry Powder Inhaler or the Turbuhaler^® in Asthmatic Patients

Respiration, Vol. 69, Iss. 6, 2002-12 ,pp. : 502-508

Karger

Access to resources Recommend Favorite

Lung Deposition of Aclidinium Bromide from Genuair®, a Multidose Dry Powder Inhaler

Respiration, Vol. 78, Iss. 3, 2009-05 ,pp. : 322-328

Karger

Access to resources Recommend Favorite

Relative systemic availability of budesonide in patients with asthma after inhalation from two dry powder inhalers

By Persson Gunnar Ankerst Jaro Gillen Michael Bengtsson Thomas Thorsson Lars

Current Medical Research and Opinion, Vol. 24, Iss. 5, 2008-05 ,pp. : 1511-1517

Informa Healthcare

Access to resources Recommend Favorite

Therapeutic Equivalence and Acceptability of Two Multidose Powder Inhalers in the Treatment of Asthma

Respiration, Vol. 67, Iss. 1, 2000-02 ,pp. : 77-82

Karger

Access to resources Recommend Favorite